Literature DB >> 7096011

Evolution of the indications and results of treatment of myasthenia by thymectomy.

H Le Brigand.   

Abstract

Four-hundred and fifty thymectomies from myasthenia were carried out at the Marie Lannelongue Surgical Center up to October 1980. This report deals with 248 patients who were operated on up to October 1977 and who were followed up for periods of 18 months to over 20 years with a view to examining the indications and results of thymectomy. In our opinion patients with thymomas should be operated upon when their general and cardiorespiratory condition allows surgery, and if there is no tumoral spread which precludes eradication. In the latter cases, irradiation and antimitotics are the only remaining resources. In 82% of the 248 patients who had a long term follow-up, results were good. In the group of patients obliged to continue regular medical treatment, thymectomy prevents deterioration, allows the patient to be administered better medical treatment, and to return to normal activity. Moreover, by reducing the risk of a tumor developing (75% of the cases), complementary irradiation treatment is avoided.

Entities:  

Mesh:

Year:  1982        PMID: 7096011

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  4 in total

1.  Differential estrogen receptor expression in autoimmune myasthenia gravis.

Authors:  Patrice Nancy; Sonia Berrih-Aknin
Journal:  Endocrinology       Date:  2005-01-20       Impact factor: 4.736

2.  Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.

Authors:  A Wakkach; S Poea; E Chastre; C Gespach; F Lecerf; S De La Porte; S Tzartos; A Coulombe; S Berrih-Aknin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

3.  Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia.

Authors:  L J McGuire; D P Huang; R Teoh; M Arnold; K Wong; J C Lee
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

4.  Thymectomy for myasthenia gravis.

Authors:  R J Moorehead; R A Spence; P Maginn; V H Patterson; J R Gibbons; H M Stevenson
Journal:  Ulster Med J       Date:  1985-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.